Inicio › Linfoma no Hodgkin › Utah › Salt Lake City
Ensayos clínicos de Linfoma no Hodgkin en Salt Lake City, UT
13 estudios para Linfoma no Hodgkin buscan participantes en centros de Salt Lake City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
ReclutandoFase 1/2
- Intermountain Health, Canyons Region, LDS Hospital, Salt Lake City
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
ReclutandoFase 2
- Intermountain Healthcare, Salt Lake City
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
ReclutandoFase 1
- Intermountain Healthcare, Salt Lake City
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
ReclutandoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
ReclutandoFase 3
- Intermountain Healthcare, Salt Lake City
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
ReclutandoFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ReclutandoEstudio observacional
- University of Utah, Salt Lake City
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
ReclutandoFase 1
- University of Utah, Salt Lake City
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
ReclutandoFase 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
ReclutandoEstudio observacional
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
ReclutandoFase 1/2
- University of Utah, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Salt Lake City
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
ReclutandoEstudio observacional
- University of Utah Hospital, Salt Lake City
Ensayos de Linfoma no Hodgkin en otras ciudades
- Houston, TX31 estudios
- New York City, NY31 estudios
- Boston, MA26 estudios
- Nashville, TN21 estudios
- Philadelphia, PA20 estudios
- Baldwin Park, CA19 estudios
- Washington, DC18 estudios
- Milwaukee, WI18 estudios
- Atlanta, GA18 estudios
- Chicago, IL18 estudios
- Columbus, OH18 estudios
- Dallas, TX17 estudios
Otros estudios en Salt Lake City
- Cáncer de pulmón de células no pequeñas31 estudios
- Cáncer (todos los tipos)27 estudios
- Cáncer de seno27 estudios
- Cáncer del colon y del recto22 estudios
- Cáncer de pulmón21 estudios
- Melanoma21 estudios
- Mieloma múltiple21 estudios
- Cáncer metastásico20 estudios
- Cáncer de ovario19 estudios
- Obesidad18 estudios
- Leucemia mielógena aguda17 estudios
- Fallo cardíaco17 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.